Literature DB >> 9114847

Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer.

A Krongrad, J Brady, R J Rodriguez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114847     DOI: 10.1097/00007611-199704000-00025

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  2 in total

1.  Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration.

Authors:  Masayoshi Zaitsu; Mariko Yamanoi; Koji Mikami; Yuta Takeshima; Naohiko Okamoto; Sadao Imao; Akiko Tonooka; Takumi Takeuchi
Journal:  Adv Urol       Date:  2011-06-15

2.  Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer.

Authors:  Yoko Koh; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Kazutoshi Fujita; Hiroshi Kiuchi; Ryoichi Imamura; Yasushi Miyagawa; Norio Nonomura; Motohide Uemura
Journal:  Anticancer Drugs       Date:  2020-11       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.